US$ 28.44
next generation glp 1 drugs GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits GLP-1 Receptor Agonists | New
Description
When your gut bacteria eat it, they produce short-chain fatty acids , which tell your body to make more GLP-1

doi: 10.1056/NEJMoa2404881

Yamagishi S, Matsui T

Plainsboro, NJ, USA: Novo Nordisk Inc (2025)
Patients with T2D not adequately controlled on therapy with metformin and insulin glargine as baseline therapy received either tirzepatide at the doses used in the SURPASS trials or placebo during the 40-week study setting

That kind of weight loss can lead to other health improvements like lowered blood pressure, blood sugar, and some blood fats, and can improve joint pain and sleep apnea
